{"organizations": [], "uuid": "96ec54901b60f9c9fbbcea3604ae079b0df2de07", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://www.reuters.com/resources/archive/us/20180131.html", "section_title": "Archive News &amp; Video for Wednesday, 31 Jan 2018 | Reuters.com", "url": "https://www.reuters.com/article/brief-zogenix-completes-enrollment-in-se/brief-zogenix-completes-enrollment-in-second-zx008-phase-3-clinical-trial-in-dravet-syndrome-idUSASB0C3BK", "country": "US", "domain_rank": 408, "title": "BRIEF-Zogenix Completes Enrollment In Second ZX008 Phase 3 Clinical Trial In Dravet Syndrome", "performance_score": 0, "site": "reuters.com", "participants_count": 1, "title_full": "", "spam_score": 0.303, "site_type": "news", "published": "2018-02-01T06:20:00.000+02:00", "replies_count": 0, "uuid": "96ec54901b60f9c9fbbcea3604ae079b0df2de07"}, "author": "Reuters Editorial", "url": "https://www.reuters.com/article/brief-zogenix-completes-enrollment-in-se/brief-zogenix-completes-enrollment-in-second-zx008-phase-3-clinical-trial-in-dravet-syndrome-idUSASB0C3BK", "ord_in_thread": 0, "title": "BRIEF-Zogenix Completes Enrollment In Second ZX008 Phase 3 Clinical Trial In Dravet Syndrome", "locations": [], "entities": {"persons": [], "locations": [], "organizations": [{"name": "reuters", "sentiment": "negative"}, {"name": "zogenix inc", "sentiment": "negative"}, {"name": "eikon", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "Jan 31 (Reuters) - Zogenix Inc:\n* ZOGENIX COMPLETES ENROLLMENT IN SECOND ZX008 PHASE 3 CLINICAL TRIAL IN DRAVET SYNDROME\n* ZOGENIX INC SAYS ‍TOP-LINE DATA ON TRACK FOR 2Q 2018 FOR SECOND PHASE 3 CLINICAL TRIAL EVALUATING ZX008​ Source text for Eikon: Further company coverage:\n ", "external_links": ["http://thomsonreuters.com/en/about-us/trust-principles.html"], "published": "2018-02-01T06:20:00.000+02:00", "crawled": "2018-02-01T14:56:43.005+02:00", "highlightTitle": ""}